Upper respiratory tract carriage and transmission of pneumococci.
Vaccines have been instrumental in preventing childhood morbidity as well as mortality. It is imperative that health professionals have all the necessary information about a vaccine before its introduction into the routine immunisation schedule. This article looks at the possible introduction of a new pneumococcal conjugate vaccine and reviews a longitudinal carriage study of pneumococcus in UK families to determine pneumococcal carriage rates.
Hussain
Mahein
M
Institute of Child Health, London.
Clark
Mark
M
Tew
Amanda
A
Williams
Lisa
L
Miller
Elizabeth
E
D002353:Carrier State / Q000382:microbiology*; D002675:Child, Preschool; D006801:Humans; D008137:Longitudinal Studies; D009305:Nasopharynx / Q000382:microbiology; D011008:Pneumococcal Infections / Q000382:microbiology / Q000517:prevention & control / Q000635:transmission*; D022242:Pneumococcal Vaccines / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000382:microbiology* / Q000517:prevention & control / Q000635:transmission*; D013296:Streptococcus pneumoniae / Q000254:growth & development* / Q000302:isolation & purification
D022242:Pneumococcal Vaccines